Crossmark

A targeted nanoplatform co-delivery of pooled siRNA and doxorubicin for reversing of multidrug resistance in breast cancer

Published Online: 2022-04-18

Published Print: 2022-07

Authors

Liu, Hongmei

Ma, Ding

Chen, Jinpeng

Ye, Li

Li, Yiping

Xie, Yuexia

Zhao, Xue

Zou, Hanbing

Chen, Xiaojing

Pu, Jun

Liu, Peifeng
License Information

Text and Data Mining valid from 2022-04-18

Version of Record valid from 2022-04-18
More Information

Article History

Received: 6 December 2021

Revised: 17 February 2022

Accepted: 20 February 2022

First Online: 18 April 2022

Document is current